HAEMATOCON 2026: Transforming the Landscape of Blood Cancer Care

Ahmedabad hosted the 67th annual ISHBT conference, HAEMATOCON 2026, which wrapped up on November 15. The event served as a major hub for 4,000 delegates and 200 international faculty members to explore breakthroughs in blood cancer treatment, early diagnosis of inherited blood disorders, and evidence-based care. Ahmedabad, November 16: The four-day gathering brought together a vast assembly of experts to examine the latest developments in haematology and their direct impact on patient outcomes.

Staged at Club O7 from November 12 to 15, the 67th annual conference of the Indian Society of Hematology and Blood Transfusion (ISHBT) featured a comprehensive agenda of research presentations, workshops, and clinical debates. Centered on the theme ‘Advancing Hematology: From Evidence to Clinical Excellence’, the event examined how modern research and diagnostic tools are reshaping the management of blood-related conditions.

HAEMATOCON 2026: New Blood Cancer Care Standards

The scientific sessions prioritized the diagnosis and management of six primary blood disorder categories: leukaemia, sickle cell disease, thalassaemia, haemophilia, anaemia and immune thrombocytopenia (ITP). Regarding leukaemia, experts reviewed the latest progress in chemotherapy, targeted therapies, immunotherapy and bone marrow transplantation, while also emphasizing the necessity of precise diagnosis and tailored treatment plans for cancer patients.

Academic tracks dedicated to inherited conditions—specifically sickle cell disease, haemophilia and thalassaemia—underscored the critical nature of early screening, genetic counselling and carrier identification, alongside the challenges of long-term patient management. Anaemia was also a key topic, with experts stressing the need to pinpoint underlying causes for effective intervention, while ITP sessions covered diagnostic assessments and the latest therapeutic developments for low platelet counts.

"HAEMATOCON 2026 highlighted how advances in medical research and treatment are changing the way blood disorders are diagnosed and managed. While significant progress has been made in treating conditions such as leukaemia, thalassaemia, sickle cell disease and other haematological disorders, early diagnosis and timely access to appropriate treatment remain equally important. The conference reinforced the need for greater public awareness, stronger collaboration among healthcare professionals and continued efforts to make modern treatment approaches more accessible to patients across India," said Dr. Tuphan K. Dolai, Secretary, ISHBT.

The conference curriculum spanned a broad spectrum, including benign and malignant haematology, transfusion medicine, molecular diagnostics and stem cell transplantation. Through interactive case studies and hands-on workshops, attendees exchanged clinical insights and explored the practical application of new medical technologies. The event drew specialists from countries including the US, UK, Germany, Australia, Japan, China and Bangladesh, fostering a global environment for scientific exchange.

"This is the first national-level conference we have organised, bringing together more than 2,000 super-specialist doctors from India and different countries. The conference featured extensive discussions on blood cancers and other blood-related disorders, available treatment options and emerging medical technologies. It provided an important platform for specialists to exchange knowledge, share clinical experiences and explore developments in the diagnosis and treatment of haematological conditions," said Dr. Amit Khurana, Organising Secretary, HAEMATOCON 2026.

A major highlight of HAEMATOCON 2026 was the emphasis on international cooperation. This included a joint symposium between the American Society of Hematology and the Indian Society of Hematology, which delved into patient care advances and treatment options. Additionally, an Asian summit brought together haematologists from South Korea, Japan, Singapore, Malaysia and Thailand to discuss conditions impacting both younger and older demographics.

"The 67th annual haematology conference in Ahmedabad brought together experts from India and across the world for meaningful scientific discussions. A joint symposium between the American Society of Hematology and the Indian Society of Hematology focused on various blood disorders, available treatments and advances in patient care. The conference also featured an Asian summit, where haematologists from South Korea, Japan, Singapore, Malaysia and Thailand exchanged knowledge and discussed haematological conditions affecting both younger and older populations. We also honoured nine veterans with the Fellowship of the Indian College of Haematology in recognition of their contributions to the field. These interactions and recognitions reflect the importance of scientific collaboration, knowledge sharing and acknowledging those who have contributed to advancing haematology," said Brig. (Dr.) Tathagata Chatterjee, President, ISHBT.

A highlight of the event was the presentation of the Fellowship of the Indian College of Haematology to nine distinguished veterans. The agenda also featured research awards, scientific presentations and an exhibition showcasing the latest in medical technology and diagnostics. Beyond clinical discourse, the conference underscored the importance of public awareness, advocating for early symptom recognition, timely medical consultation, and increased participation in voluntary blood donation and stem cell donor registries.

"HAEMATOCON 2026 has provided an important platform for specialists from India and across the world to exchange knowledge and discuss the latest developments in haematology. The discussions over the four days highlighted the importance of early diagnosis, evidence-based treatment and continued research in improving outcomes for patients with blood disorders. Such scientific gatherings play a vital role in strengthening collaboration among medical professionals and bringing advances in medical science closer to everyday clinical practice," said Dr. R K Jena, Secretary, ICH.

A recurring theme throughout the event was the necessity of ongoing international collaboration in medical research, particularly regarding the management of life-threatening blood disorders and the sharing of innovative diagnostic and treatment strategies.

"HAEMATOCON 2026 received an overwhelming response from the medical community across the globe, bringing together hundreds of experts from India and other countries. The conference provided an excellent opportunity for specialists to learn, exchange ideas, build professional networks and explore collaborative research. With continued efforts being made to find effective treatments and cures for life-threatening blood disorders, international cooperation has become increasingly important. Just as the world came together to fight COVID-19, the medical community must work collectively to share knowledge, research and emerging technologies. HAEMATOCON 2026 was organised with this very objective of strengthening global collaboration and accelerating progress in haematology," said Lt. Gen. Dr. Velu Nair, Organising Chairman, HAEMATOCON 2026.

HAEMATOCON 2026 concluded by synthesizing discussions on scientific research, novel treatment modalities and the imperative to improve public understanding of blood-related conditions. The event successfully bridged the gap between medical innovation and clinical practice, while fostering a spirit of collaboration among haematology specialists both within India and internationally.

24K Gold / Gram
22K Gold / Gram
Advertisement
First Name
Last Name
Email Address
Age
Select Age
  • 18 to 24
  • 25 to 34
  • 35 to 44
  • 45 to 54
  • 55 to 64
  • 65 or over
Gender
Select Gender
  • Male
  • Female
  • Transgender
Location
Explore by Category
Get Instant News Updates
Enable All Notifications
Select to receive notifications from